Cardiol Therapeutics Inc (CRDL) Stock Price & News

All values in CAD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	4.79M	2.74M	4.95M	3.20M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	5.39M	5.29M	4.76M	4.74M
Operating expense	10.18M	8.03M	9.71M	7.94M
Total operating expenses	10.18M	8.03M	9.71M	7.94M
Operating income	-10.18M	-8.03M	-9.71M	-7.94M
Other non operating income	-	951.74K	-1.53M	1.35M
EBT including unusual items	-9.96M	-7.21M	-10.82M	-6.08M
EBT excluding unusual items	-9.96M	-7.21M	-10.82M	-6.08M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-9.96M	-7.21M	-10.82M	-6.08M
Net profit margin	-	-	-	-
Earnings per share	-0.12	-0.07	-0.10	-0.05
Interest and investment income	122.26K	175.21K	200.72K	201.33K
Interest expense	-	-	-	-
Net interest expenses	122.26K	175.21K	200.72K	201.33K
Depreciation and amortization charges	-	-	-	-
EBITDA	-10.17M	-8.02M	-9.70M	-7.93M
Gain or loss from assets sale	-	-	-	-

Ask anything